Amberjack Capital Partners, L.P. has filed a Form 13F-HR with the Securities and Exchange Commission, disclosing its equity portfolio as of March 31, 2026. The filing indicates that the firm holds a single position in Innovex International Inc.
According to the information table within the filing, Amberjack Capital Partners holds 22,757,322 shares of Innovex International Inc. common stock. The position is valued at $0, as disclosed in the filing.
The filing was signed by John Christopher Trampe, the firm's Chief Compliance Officer, on November 2, 2026.
